The Commercial Marketing Provisions of the Biologics Act are Mandatory
In Amgen Inc. v. Apotex Inc., [2016-1308] (July 5, 2016), the Federal Circuit affirmed a preliminary injunction against Apotex from entering the market until 180 days after giving Amgen Notice after receiving its FDA license. The Federal Circuit held that … Continue reading The Commercial Marketing Provisions of the Biologics Act are Mandatory
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed